336 related articles for article (PubMed ID: 17577104)
1. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine.
Yamagishi T
Hypertens Res; 2006 Oct; 29(10):767-73. PubMed ID: 17283863
[TBL] [Abstract][Full Text] [Related]
3. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
4. Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients.
Zhao X; Wu F; Jia S; Qu P; Li H; Zhao X; Cao B; Lin Y; Wang M
Clin Exp Hypertens; 2010; 32(6):372-6. PubMed ID: 21029001
[TBL] [Abstract][Full Text] [Related]
5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H
Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.
Shokoji T; Fujisawa Y; Kiyomoto H; Rahman M; Sun GP; Fan YY; Kimura S; Kohno M; Abe Y; Nishiyama A
Hypertens Res; 2005 Dec; 28(12):1017-23. PubMed ID: 16671342
[TBL] [Abstract][Full Text] [Related]
8. Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine.
Fujisawa M; Yorikane R; Chiba S; Koike H
J Cardiovasc Pharmacol; 2009 Apr; 53(4):325-32. PubMed ID: 19295444
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
Inomata J; Murai H; Kaneko S; Hamaoka T; Ikeda T; Kobayashi D; Usui S; Furusho H; Sugiyama Y; Takata S; Takamura M
J Hypertens; 2014 Sep; 32(9):1898-904. PubMed ID: 24979307
[TBL] [Abstract][Full Text] [Related]
10. Effects of azelnidipine on the autonomic functions and its influence on arterial stiffness and endothelial functions.
Yamada J; Tomiyama H; Matsumoto C; Yoshida M; Shiina K; Yamashina A
J Cardiol; 2008 Apr; 51(2):114-20. PubMed ID: 18522784
[TBL] [Abstract][Full Text] [Related]
11. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Ding YA; Chang SM; Chou TC
J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
[TBL] [Abstract][Full Text] [Related]
13. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
14. The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients.
Suzuki H; Inoue T; Kobayashi K; Shoda J; Nakamoto H
Adv Perit Dial; 2006; 22():18-23. PubMed ID: 16983932
[TBL] [Abstract][Full Text] [Related]
15. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of azelnidipine in comparison with those of amlodipine assessed in the halothane-anaesthetized dog.
Ishizaka T; Takahara A; Iwasaki H; Mitsumori Y; Kise H; Nakamura Y; Sugiyama A
Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):135-43. PubMed ID: 19906049
[TBL] [Abstract][Full Text] [Related]
17. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
18. Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.
Abe M; Maruyama N; Okada K; Matsumoto S; Matsumoto K; Soma M
Hypertens Res; 2011 Aug; 34(8):935-41. PubMed ID: 21654755
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-acting ACE inhibitor (temocapril) and long-acting Ca channel blocker (amlodipine) on 24-h ambulatory BP in elderly hypertensive patients.
Eguchi K; Kario K; Shimada K
J Hum Hypertens; 2001 Sep; 15(9):643-8. PubMed ID: 11550111
[TBL] [Abstract][Full Text] [Related]
20. Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
Nagasu H; Satoh M; Fujimoto S; Tomita N; Sasaki T; Kashihara N
Hypertens Res; 2012 Mar; 35(3):348-55. PubMed ID: 22072106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
